EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Multidimensional Efficacy between Methylphenidate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: A 12-Week Randomized Controlled Trial

雪竹 黄

International Journal of Psychiatry and Neurology · 2026 · 15 (04) · 135-154

DOI: 10.12677/ijpn.2026.154016 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Psychiatry and Neurology, 2026. Verfasst von 雪竹 黄. Die Arbeit nennt 32 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

黄, 雪. (2026). Multidimensional Efficacy between Methylphenidate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: A 12-Week Randomized Controlled Trial. International Journal of Psychiatry and Neurology, 15(04), 135-154. https://doi.org/10.12677/ijpn.2026.154016

Vancouver

黄 雪. Multidimensional Efficacy between Methylphenidate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: A 12-Week Randomized Controlled Trial. International Journal of Psychiatry and Neurology. 2026;15(04):135-154. doi:10.12677/ijpn.2026.154016

BibTeX
@article{2026,
  author = {黄, 雪竹},
  title = {Multidimensional Efficacy between Methylphenidate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: A 12-Week Randomized Controlled Trial},
  journal = {International Journal of Psychiatry and Neurology},
  year = {2026},
  volume = {15},
  number = {04},
  pages = {135--154},
  doi = {10.12677/ijpn.2026.154016}
}
Kostenlos starten →